NL-OMON35059尚未招募不适用
Pre-operative CT scan in breast conserving therapy for more accurate radiation boost volume delineation. - PRESCRIBE
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •cT1-3N0 breastcancer, calculated creatinine clearance > 60 ml/liter (Cockroft) , informed consent
排除标准
- •post operative mastitis or wounddefect, contra indication for iv.contrast, neo adjuvant systemic treatment
研究者
相似试验
尚未招募
不适用
Clinical evaluation of Contrast Enhanced Breast CT in women recalled from screening due to calcificationsMamma calcifications10006291breast cancerNL-OMON56633Radboud Universitair Medisch Centrum539
招募中
不适用
Clinical evaluation of Contrast Enhanced Breast CT to improve Staging and treatment follow up in women with breast cancerMamma carcinoma10006291breast cancerNL-OMON54169Radboud Universitair Medisch Centrum413
已完成
不适用
Evaluation of the usefulness of breast CT imaging in delineating tumor extent and guiding surgical management: a prospective multi-institutional studybreast cancerJPRN-UMIN000005029Grants for Scientific Research from the Expenses for Health and Welfare Program (17-7) from the Ministry of Health, Labour and Welfare of Japan300
已完成
不适用
Pre-operative Contrast Enhanced CT to Improve Delineation of the Tumorbed in Radiotherapy for Breast Cancer.Breast CancerNCT00721058Maastricht Radiation Oncology60
进行中（未招募）
不适用
Preoperative treatment of breast cancer with a combination of epirubicin, docetaxel and bevacizumab. A translational trial on molecular markers and functional imaging to predict response early - PROMIXPatients diagnosed with breast cancer who are candidates for preoperative (neoadjuvant) chemotherapy due to localized primary breast cancer including inflammatory breast cancer suitable for primary medical treatment and/or regional lymph node metastases including ipsilateral supraclavicular nodes with breast cancer diagnosis confirmed by histological examination.MedDRA version: 9.1Level: LLTClassification code 10006200Term: Breast cancer stage IIMedDRA version: 9.1Level: LLTClassification code 10006201Term: Breast cancer stage IIIMedDRA version: 9.1Level: LLTClassification code 10021974Term: Inflammatory breast cancerEUCTR2007-005858-23-SEPROMIX Trial Group200